45 results on '"Cerbone, Luigi"'
Search Results
2. Activity of Systemic Treatments After Cabozantinib Failure in Advanced Metastatic Renal Cell Carcinoma
3. MARS 2 trial: the future of pleurectomy decortication in pleural mesothelioma
4. Pathological complete response in a patient with pleural mesothelioma treated with immunotherapy: a case report
5. Liquid Biopsies for Circulating Tumor DNA Detection May Reveal Occult Hematologic Malignancies in Patients With Solid Tumors
6. Immunotherapy of mesothelioma: the evolving change of a long-standing therapeutic dream
7. Clinical Next Generation Sequencing Application in Mesothelioma: Finding a Golden Needle in the Haystack
8. Prognostic Variables in Patients With Non-metastatic Small-cell Neuroendocrine Carcinoma of the Bladder: A Population-Based Study
9. Overexpression of Periostin in Tumor Biopsy Samples Is Associated With Prostate Cancer Phenotype and Clinical Outcome
10. Therapeutic sequencing in the era of first-line immune checkpoint inhibitor combinations, a novel challenge in patients with metastatic clear-cell renal cell carcinoma
11. CDK4/6 inhibitors in advanced hormone receptor-positive/HER2-negative breast cancer: a systematic review and meta-analysis of randomized trials
12. Supplementary Tables S1-S11 from Integrative Pan-Cancer Genomic and Transcriptomic Analyses of Refractory Metastatic Cancer
13. Supplementary Figures S1-S24 from Integrative Pan-Cancer Genomic and Transcriptomic Analyses of Refractory Metastatic Cancer
14. Data from Integrative Pan-Cancer Genomic and Transcriptomic Analyses of Refractory Metastatic Cancer
15. Data from The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy Individuals
16. Abstract 6570: Integrative pan-cancer genomic and transcriptomic analyses of refractory metastatic cancer
17. Supplementary Data from The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy Individuals
18. Supplementary Figure from The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy Individuals
19. Integrative Pan-Cancer Genomic and Transcriptomic Analyses of Refractory Metastatic Cancer
20. Reduced dose of cabazitaxel in metastatic castration-resistant prostate cancer: from PROSELICA trial to the real life: A single institution experience
21. The Lung Immune Prognostic Index (LIPI) stratifies prognostic groups and correlates with gut microbiota (GM) in patients with advanced renal cell carcinoma (RCC).
22. Abstract PR009: Integrative pan-cancer genomic and transcriptomic analyses of refractory metastatic cancer
23. Unprecedented long‐term survival in a patient with malignant pleural mesothelioma treated with subsequent systemic chemo‐ and immunotherapeutic regimens
24. Combined Response of Advanced Cutaneous Squamous Cell Carcinoma and Renal Cell Carcinoma to Immunotherapy: A Case Report
25. Pericardial Mesothelioma, a Disease for Brave Hearts
26. Integrative pan-cancer genomic and transcriptomic analyses of refractory metastatic cancer
27. High-dose fotemustine in temozolomide-pretreated glioblastoma multiforme patients: A phase I/II trial
28. Efficacy of first-line combination therapy in metastatic renal cell carcinoma (mRCC) patients (pts) with poor performance status (PS).
29. Application of the Meet-URO score to metastatic renal cell carcinoma patients treated with second- and third-line cabozantinib
30. Durable response after immunotherapy discontinuation for delayed and severe immune-related adverse events: a case report
31. Circulating acetylated polyamines correlate with Covid-19 severity in cancer patients
32. Response to systemic therapy in fumarate hydratase–deficient renal cell carcinoma
33. The Effect of Concomitant Proton Pump Inhibitor and Cabozantinib on the Outcomes of Patients with Metastatic Renal Cell Carcinoma
34. An overview of osimertinib as a treatment of non-small cell lung cancer (NSCLC): an update
35. Association of cabozantinib residual concentration (Ctrough) and blood clearance (Cl/F) with toxicity (tox) and progressive disease (PD) in metastatic renal cell carcinoma (mRCC) patients (pts): Results from a monocentric pharmacokinetics (PK) study.
36. Combination therapy in metastatic renal cell carcinoma: Back to the future?
37. Abscopal effect after hypofractionated radiotherapy in metastatic renal cell carcinoma pretreated with pazopanib
38. ADP ribose polymerase inhibitors for treating non-small cell lung cancer: new additions to the pharmacotherapeutic armamentarium
39. Targeted therapy of oncogenic-driven advanced non-small cell lung cancer: recent advances and new perspectives
40. Role of Circulating Tumor Cells (CTC), Androgen Receptor Full Length (AR-FL) and Androgen Receptor Splice Variant 7 (AR-V7) in a Prospective Cohort of Castration-Resistant Metastatic Prostate Cancer Patients
41. CDK inhibitors in advanced HR+ Her 2- breast cancer: A systematic review and meta-analysis of randomized trials.
42. Prognostic variables in localized small cell neuroendocrine carcinoma of the bladder: A population-based study.
43. Nivolumab in pretreated pleural mesothelioma: Results from an observational real-world study of patients treated within the AIFA 5% Fund
44. The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy Individuals.
45. Brachioradial pruritus in a 47-year-old woman treated with pregabalin.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.